Oct 2, 2024, 18:59
Jin Zhang: Exploring Precision Treatment in Breast Cancer and Advances in Anti-HER2 Therapy – MediaMedic
MediaMedic shared a post on LinkedIn:
“2024 COMB丨Dr. Jin Zhang: Exploring Precision Treatment in Breast Cancer and Advances in Anti-HER2 Therapy
At the 7th Oncology Precision Diagnosis and Treatment Conference (COMB 2024), Dr. Jin Zhang from Tianjin Medical University Cancer Institute and Hospital led discussions on cutting-edge regional breast cancer management. The focus was on de-escalation in early-stage surgery and the evolving landscape of anti-HER2 therapy in advanced breast cancer.
Dr. Zhang’s insights highlight the promising strides in individualized treatment, reflecting a more precise approach to breast cancer care in China.”
Source: MediaMedic/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12